
CGM Pharmacy Copay Program
Medtronic Diabetes is committed to supporting access and addressing higher out-of-pocket costs.
Pay as little as $60 for a one-month supply of sensors
If you are commercially insured and have pharmacy benefit coverage for the Medtronic continuous glucose monitors (CGM), you may be eligible. This program applies to:
- Guardian™ 4 sensor
- Simplera Sync™ sensor (for use with the MiniMed™ 780G system)
- Simplera™ CGM (for use with the InPen™ smart insulin pen system)
For the Guardian™ 4 transmitter, pay as little as $99 per transmitter! Applicable one time per year.

How it works
If you have insurance coverage for the Medtronic CGM through your pharmacy benefit, and meet other eligiblity terms, the copay assistance will be automatically applied at the pharmacy.
Frequently asked questions
Who is eligible for the CGM Pharmacy Copay Program?
You may be eligible for this program if you meet the following requirements:
- You have commercial health insurance.
- You have a valid prescription for your Medtronic CGM from your healthcare professional.
- You have coverage for CGMs under your health plan’s pharmacy benefit.
What if I’m not eligible for this program?
Eligibility is determined based on insurance coverage. You can call us at 800-646-4633 (Monday - Friday, 8 a.m. - 6 p.m. CT) to verify both your medical benefit for supplies and your pharmacy coverage to determine your lowest out-of-pocket cost. If you do not have any insurance coverage for the prescribed CGM, you may be eligible for other financial support programs from Medtronic.
How does the copay program work?
This copay support program will be automatically applied to your out-of-pocket balance due when you obtain the CGM through the Medtronic Pharmacy or other pharmacy within the vendor network.
Will the copay support be applied to my coinsurance or deductible as well?
This copay support would be applied to the amount you owe when the pharmacy claim is adjudicated.
Which products are included in this program?
This program is valid for: the Guardian™ 4 sensor and transmitter, Simplera Sync™ sensor, and Simplera™ CGM.
CGM Pharmacy Copay Program Terms & Conditions
- Valid prescription from provider required.
- Eligible patients: Commercially insured patients only; with coverage through their pharmacy benefit.
- Excluded participants include patients enrolled in any federal, state, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD) or TRICARE® that provides coverage for G4S, or where prohibited by law (including MA and MI).
- If at any time a patient becomes enrolled under any such federal, state, or government-funded healthcare program, he/she will no longer be able to use this program and must call (858) 522-0252 to stop participation.
- For the Guardian™ 4 sensor and transmitter: patients can receive up to a total of $500 maximum annual benefit for their annual transmitter. Patients can receive up to a total of $720 annual benefit for their sensors, with a monthly maximum benefit of $180 per month.
- For Simplera™ and Simplera Sync™ sensors: Patients can receive up to a total of $2000 annual benefit for their sensors, and a monthly maximum benefit of $380/month.
- Program valid for eligible patients filling a prescription after December 13, 2024. There is no retroactive application of this program.
- Customer agrees not to submit any claims for rebated products to any Government Plan and will not request their pharmacy or DME supplier to submit any such claim to any Government Plan.
- Restrictions may apply. If the Medtronic CGM is not covered on your plans formulary, this program will not apply.
- Offer and terms and conditions are subject to change or discontinue without notice.
- This is not health insurance.
- Offer good only in the USA at participating pharmacies and cannot be redeemed at government-subsidized clinics.
Important Safety Information: MiniMed™ 780G system with SmartGuard™ technology with Simplera Sync™ sensor
The MiniMed™ 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Simplera Sync™ sensor can be used one time and has a life up to 6 days, followed by a grace period of 24 hours. During the grace period, the sensor will continue to work as it did during the first 6 days, to allow the patient to change their sensor more flexibly. However, some sensors may not survive the full wear period for a variety of reasons. Please be prepared to replace the sensor during the grace period to ensure sensor glucose values continue to be monitored.
The Simplera Sync™ sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Simplera Sync™ sensor. The Simplera Sync™ sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Simplera Sync™ sensor in the abdomen or other body sites, including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
The Medtronic MiniMed™ 780G System consists of the following devices: MiniMed™ 780G Insulin Pump, Simplera Sync™ sensor, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide Test Strips. The system requires a prescription from a healthcare professional.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library
Important Safety Information: MiniMed™ 780G system with SmartGuard™ technology with Guardian™ 4 sensor
The MiniMed™ 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G Insulin Pump, the Guardian™ 4 Transmitter, the Guardian™ 4 Sensor, One-press serter, the Accu-Chek™Guide Link blood glucose meter, and the Accu-Chek™Guide Test Strips. The system requires a prescription from a healthcare professional.
The Guardian™ 4 Sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ (4) sensor is indicated for up to seven days of continuous use.
The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library